Prozac is a fluoxetine capsule product in the SSRI class. Its US label covers several psychiatric conditions, with different pediatric limits and a separate distinction between fluoxetine alone and treatment combined with olanzapine.
The approved uses and formulations described here follow US prescribing information. They may differ in other countries.
| Medicine detail | Details |
|---|---|
| Active ingredient(s) | fluoxetine hydrochloride (strengths expressed as fluoxetine) |
| Medicine class | Selective serotonin reuptake inhibitor (SSRI) |
| Forms and strengths | Oral capsules: 10, 20 and 40 mg; this reference excludes weekly delayed-release and other fluoxetine presentations |
Uses depend on the condition and age
Prozac is labeled for major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder. Pediatric evidence supports major depressive disorder from age 8 and OCD from age 7; these limits do not extend to every indication. This page concerns the daily oral capsules in the cited label.
Source: [1]
Combination uses are a separate distinction
Depressive episodes associated with bipolar I disorder and treatment-resistant depression are labeled uses of Prozac with olanzapine, rather than Prozac alone. Those combinations carry additional warnings. A reference to fluoxetine must not be read as permission to add olanzapine or to treat bipolar depression without specialist assessment.
Source: [1]
Capsules and a planned course of treatment
The cited capsules contain 10, 20 or 40 mg of fluoxetine. Treatment and any reduction are prescribed according to the condition, response and tolerability. Fluoxetine and its active metabolite persist after stopping, so effects and interactions can continue beyond the final capsule.
Source: [1]
Mood monitoring and other warnings
The boxed warning concerns increased suicidal thoughts and behaviors in children, adolescents and young adults taking antidepressants. Monitor worsening symptoms at all ages. Other important risks include serotonin syndrome, bleeding, low sodium, mania and QT prolongation. Urgent assessment is needed for severe agitation with fever or other suspected serious reactions.
Source: [1]
Allow for the long interaction interval
MAO inhibitors must not be combined with Prozac. The label requires at least five weeks after stopping Prozac before an MAOI intended for psychiatric treatment, and at least 14 days after stopping that MAOI before Prozac. Pimozide and thioridazine are also restricted. A prescriber must plan transitions and check all medicines.
The Prozac and Zoloft comparison provides a separate side-by-side reference, without establishing an individual treatment choice.
Source: [1]
Questions and answers
Does Prozac alone have a bipolar-depression indication?
No. The cited bipolar I depression indication is for use with olanzapine, with the additional combination warnings.
Are weekly fluoxetine products included here?
No. This reference is scoped to the 10, 20 and 40 mg daily capsules in the cited Prozac label.
Why can interactions remain after Prozac is stopped?
Fluoxetine and its active metabolite leave the body slowly. A clinician must account for this when planning another medicine.
Related reading
Sources
Sources checked 27 October 2026. This information does not replace advice from your healthcare professional. For complete warnings and instructions, read the product information and consult the prescribing team.
Reviewed by: Mattias Hagman, PhD
About the reviewer:
Dr Mattias Hagman (PhD, University of Sydney) has an academic background and experience working with healthcare-related content and regulated industries. He has lecturing experience at international universities, including Stockholm University and the University of Malta.
Last reviewed: October 2026